DIR Return Create A Forum - Home
       ---------------------------------------------------------
       Road2HardCoreIron
  HTML https://road2hardcoreiron.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: News
       *****************************************************
       #Post#: 6996--------------------------------------------------
       The New Oral Testosterone in USA Does it Work (Kyzatrex)
   DIR By: Road2HardCoreIron
       Date: May 1, 2026, 6:52 pm
       ---------------------------------------------------------
       The Abroad Andriol is already in the Oil capsule. This works
       fine.  I'm confused with the Kyzatrex without an oil capsule?
  HTML https://www.bing.com/search?q=Kyzatrex&form=IPRV10
  HTML https://www.bing.com/videos/riverview/relatedvideo?q=new+prescription+testosterone+pill&mid=8A733EE363A3F6DC70878A733EE363A3F6DC7087&churl=https%3a%2f%2fwww.youtube.com%2fchannel%2fUCoLNk-4LAYsbfsQwjFWG2gQ&FORM=VIRE
       Oral testosterone replacement therapy (TRT) has evolved
       significantly, with Jatenzo, Tlando, and Kyzatrex representing
       the current FDA-approved options exploiting testosterone
       undecanoate (TU) absorption through intestinal lymphatics to
       avoid hepatotoxicity.
       1. Mechanism of Action
       All three oral pills use testosterone undecanoate, a lipophilic
       ester, with lipid-based delivery systems (SEDDS) to enhance
       intestinal lymphatic absorption. This bypasses first-pass
       hepatic metabolism and minimizes liver risk—a major limitation
       of older oral formulations like methyltestosterone or
       fluoxymesterone.
       2. FDA Approvals and Dosing
       Feature
       Jatenzo
       Tlando
       Kyzatrex
       FDA Approval
       Mar 2019
       Mar 2022
       Jul 2022
       Capsule Strengths
       158mg, 198mg, 237mg
       112.5mg (fixed)
       100mg, 150mg, 200mg
       Starting Dose
       237mg BID
       225mg BID
       200mg BID
       Titration
       Yes
       No (fixed)
       Yes
       Efficacy Rate
       87%
       80%
       88%
       Food Requirement
       With meals
       With meals
       With any meal
       Approx Monthly Cost
       $600–$1,200
       $450–$900
       $179 (cash)
       Key Differences:
       Jatenzo: Flexible titration, longest track record, higher
       monitoring requirements, first FDA-approved oral TRT.
       Tlando: Fixed-dose regimen, avoids titration visits, slightly
       lower efficacy (80%), may be convenient for patients seeking
       simplicity.
       Kyzatrex: Flexible titration, lowest out-of-pocket cost,
       phystosterol-based formulation allowing absorption with any
       meal.
       3. Efficacy
       Clinical trials demonstrate 80–88% of patients achieve eugonadal
       testosterone levels.
       Jatenzo and Kyzatrex: require titration for optimal dosing.
       Tlando: fixed-dose, reducing lab visit frequency but may under-
       or over-treat some patients.
       4. Safety and Monitoring
       Class-wide risks: modest blood pressure elevation, polycythemia
       (elevated hematocrit), lipid changes, PSA elevation.
       Blood pressure effects:
       Jatenzo: 3–6 mmHg increase
       Tlando: 3–5 mmHg increase
       Kyzatrex: 1.7 mmHg increase (lowest)
       Requires routine monitoring of blood pressure, hematocrit, PSA,
       and lipids.
       No clinically significant liver toxicity reported with modern
       SEDDS-based oral TU.
       5. Practical Considerations
       Advantages of Oral TRT
       Needle-free administration (avoids injections)
       No transfer to partner/children (unlike transdermal gels)
       Potentially lower erythrocytosis risk compared to injectables
       Possibly less suppressive to fertility due to pulsatile daily
       dosing
       Considerations vs Injectable Testosterone
       Injectable forms (cypionate, enanthate) have nearly 100%
       bioavailability, precise dose control, lower cost ($30–$50/mo
       generic), and weekly dosing.
       Oral formulations are more convenient, but dosing and absorption
       can vary among patients. Cost is higher, ranging from $179
       (Kyzatrex) to over $1,000 (Jatenzo) monthly.
       6. Emerging Options
       DITEST (DNL-0300): A next-generation oral native testosterone
       formulation that may allow dosing with or without food
       generating more physiologic DHT levels, currently in clinical
       trials.
       7. Summary
       Choice of oral TRT depends on patient priorities:
       Jatenzo: suitable for patients willing to titrate, with
       insurance coverage, and prefer the longest-established product.
       Tlando: fixed-dose for simplicity, less monitoring, acceptable
       efficacy.
       Kyzatrex: cost-effective, titratable, flexible food
       requirements, suitable for insurance-limited contexts.
       Injectable TRT remains superior in cost-effectiveness,
       bioavailability, and predictable serum levels, but oral
       formulations offer convenience, needle-free administration, and
       partial fertility preservation.
       Bottom Line
       Oral TRT pills, including Jatenzo, are safe and effective
       alternatives to injections for appropriately selected men with
       hypogonadism, with differences primarily in titration
       flexibility, cost, and monitoring requirements. Careful patient
       selection and ongoing monitoring remain critical to optimize
       outcomes.
       *****************************************************
       Page 1 of 1